Anthrax Disease: Symptoms, Causes & Treatment Guide

---

What Is Anthrax?

Anthrax is a serious infectious disease caused by the spore-forming bacterium Bacillus anthracis. It is primarily a disease of animals — particularly herbivores like cattle, sheep, goats, and horses — but it can and does infect humans under certain conditions. The disease has been known to humanity for thousands of years, with descriptions matching anthrax appearing in ancient texts from Egypt, Greece, and Rome.

What makes anthrax uniquely dangerous is not the bacterium itself, but its ability to form spores — dormant, microscopic capsules that can survive in soil, on surfaces, and in the environment for decades to centuries. These spores are extraordinarily resistant to heat, desiccation, UV radiation, and many disinfectants. When conditions become favorable, spores germinate back into active bacteria and begin producing powerful toxins that attack the body rapidly.

Anthrax is found naturally on every continent except Antarctica. It is most common in agricultural regions of Central and South America, sub-Saharan Africa, Central and Southwestern Asia, Southern and Eastern Europe, and the Caribbean. In the United States, natural anthrax cases occur sporadically — primarily in livestock in the western states.

---

What Causes Anthrax? The Science Behind the Bacteria

Anthrax is caused exclusively by Bacillus anthracis — a gram-positive, rod-shaped bacterium that produces some of the most potent bacterial toxins known to science. Understanding how this organism causes disease helps explain why anthrax can be so rapidly life-threatening once symptoms appear.

How Anthrax Toxins Destroy the Body

Once anthrax spores enter the body and germinate, the active bacteria produce three key proteins that combine to form two deadly toxins:

• Lethal Toxin (LeTx) — Destroys immune cells called macrophages, crippling the body’s first line of defense and triggering a massive inflammatory cascade that leads to shock and organ failure.
• Edema Toxin (EdTx) — Disrupts cell signaling, causing massive fluid leakage from cells and tissues — resulting in severe swelling (edema) and further immune suppression.

These toxins work rapidly and can reach lethal concentrations in the bloodstream even after antibiotics have killed the bacteria. This is one of the most dangerous aspects of anthrax — by the time bacteria are eliminated, the toxins they have already released may continue causing fatal damage independently.

How Humans Get Infected

Humans acquire anthrax through three primary routes of exposure, each leading to a different form of the disease with distinct symptoms and severity:

• Skin contact — Handling infected animals, animal products (hides, wool, bone meal), or contaminated soil allows spores to enter through cuts or abrasions in the skin
• Inhalation — Breathing in anthrax spores — most commonly in occupational settings like wool mills or tanneries, or through deliberate aerosolization in bioterrorism
• Ingestion — Eating undercooked meat from infected animals, more common in developing countries where food safety regulations are limited
• Injection — A fourth, emerging route identified primarily among intravenous drug users in Europe who injected contaminated heroin

Importantly, anthrax does not spread from person to person. You cannot catch anthrax from someone who is infected — it is exclusively transmitted from the environment or infected animals to humans.

---

Types of Anthrax Infection in Humans

The route of exposure determines which type of anthrax develops — and the type of anthrax largely determines how severe and how rapidly life-threatening the disease becomes. Understanding the four types is essential to recognizing anthrax disease symptoms, causes, and treatment in real-world scenarios.

Type	Route of Infection	Fatality Rate (Untreated)	How Common
Cutaneous	Skin contact	~20% untreated; <1% treated	Most common (~95% of cases)
Inhalation	Breathing spores	~80% even with treatment	Rare but most deadly
Gastrointestinal	Eating infected meat	25–60% untreated	Uncommon
Injection	Contaminated drug injection	~34%	Rare — Europe primarily

---

Anthrax Symptoms: What to Watch For

The symptoms of anthrax vary dramatically depending on which type has developed. In all forms, early recognition is critical — the window between initial symptoms and life-threatening deterioration can be devastatingly short, particularly in inhalation and gastrointestinal anthrax.

1. Cutaneous Anthrax Symptoms

Cutaneous anthrax is the mildest and most treatable form — accounting for approximately 95% of all natural human anthrax cases. It begins when spores enter the body through a break in the skin, typically on exposed areas like the hands, arms, face, or neck.

• A small, raised, itchy bump resembling an insect bite appears within 1–5 days of exposure
• The bump progresses to a fluid-filled blister (vesicle) within 1–2 days
• The blister ruptures and forms a painless ulcer with a characteristic black, coal-like center (eschar) — the hallmark of cutaneous anthrax
• Surrounding tissue swelling can be dramatic — sometimes involving the entire face or limb
• Fever, fatigue, and swollen lymph nodes may accompany the skin lesion
• The eschar typically dries, loosens, and falls off within 1–2 weeks with treatment

The black eschar is notably painless — a feature that immediately distinguishes it from infected spider bites or other skin conditions that it may superficially resemble.

2. Inhalation Anthrax Symptoms

Inhalation anthrax — also called pulmonary anthrax — is the most feared form of the disease. It occurs when anthrax spores are breathed into the lungs, where they are transported to lymph nodes in the chest, germinate, and release massive amounts of toxin into the bloodstream. It is the form associated with bioterrorism and carries an extremely high mortality rate even with aggressive treatment.

The disease progresses in two distinct phases:

• Early phase (Days 1–5) — Mild, nonspecific symptoms easily mistaken for influenza: low-grade fever, fatigue, mild chest discomfort, muscle aches, dry cough, and headache. Many patients feel briefly better before the second phase strikes.
• Late phase (rapid deterioration) — Sudden onset of high fever, severe difficulty breathing, drenching sweats, cyanosis (bluish skin), and shock. Widening of the mediastinum (the space between the lungs) visible on chest X-ray is a classic radiological sign. Without immediate treatment, death can occur within 24 to 36 hours of the second phase beginning.

3. Gastrointestinal Anthrax Symptoms

Gastrointestinal anthrax occurs after eating contaminated, undercooked meat from infected animals. It can affect the upper digestive tract (oropharyngeal) or the lower intestines (intestinal), each presenting differently.

• Oropharyngeal — Severe sore throat, difficulty swallowing, swollen neck lymph nodes, fever, and the development of ulcers in the throat or tonsils with characteristic dark eschar
• Intestinal — Nausea, vomiting (sometimes bloody), severe abdominal pain, fever, and profuse diarrhea (sometimes bloody). Can rapidly progress to septicemia and death without treatment.

4. Injection Anthrax Symptoms

First identified in heroin users in Scotland and Germany in 2009–2010, injection anthrax presents with severe soft tissue infection, swelling, and abscess formation at injection sites. It progresses rapidly to septicemia and meningitis — inflammation of the membranes surrounding the brain — and carries a mortality rate of approximately one in three even with treatment.

---

Who Is Most at Risk?

Anthrax does not affect everyone equally. Certain occupations, behaviors, and geographic locations significantly elevate the risk of exposure. Knowing whether you fall into a high-risk category allows you to take appropriate preventive measures.

Risk Group	Reason for Elevated Risk
Livestock farmers and veterinarians	Direct contact with potentially infected animals and carcasses
Wool, hide, and leather workers	Processing animal products that may carry anthrax spores
Laboratory workers	Handling Bacillus anthracis cultures or infected specimens
Military personnel	Potential bioterrorism exposure in conflict zones
Travelers to endemic regions	Exposure to infected animals or animal products in high-risk countries
People consuming uninspected bush meat	Eating meat from animals that may have died from anthrax
Intravenous drug users	Risk of injection anthrax from contaminated heroin supply

---

How Is Anthrax Diagnosed?

Diagnosing anthrax requires a combination of clinical suspicion and laboratory confirmation. Because anthrax is rare in most developed countries, it is frequently not considered immediately — which is one reason why inhalation anthrax carries such a high mortality rate. The early symptoms are deceptively similar to common respiratory illnesses.

Laboratory Tests Used to Confirm Anthrax

• Blood culture — Growing Bacillus anthracis from a blood sample; can confirm systemic infection but takes 24–48 hours
• PCR (Polymerase Chain Reaction) — Detects anthrax DNA in blood, skin lesion fluid, or respiratory secretions; faster and highly sensitive
• Gram stain and culture of lesion material — For cutaneous anthrax, fluid from the skin lesion is examined under a microscope and cultured
• Chest X-ray or CT scan — In suspected inhalation anthrax, imaging reveals characteristic widening of the mediastinum and pleural effusions
• ELISA serology — Detects anthrax-specific antibodies in blood; useful for confirming past exposure

Critically, anthrax is a notifiable disease in most countries. Any suspected case must be immediately reported to public health authorities — not only to ensure the patient receives appropriate treatment but also to investigate the source and prevent further exposure.

---

Anthrax Treatment: What Medicine Can Do

Unlike many emerging infectious diseases, anthrax has well-established treatment protocols — but their effectiveness depends almost entirely on how early treatment begins. In inhalation anthrax, every hour of delay dramatically worsens the prognosis. This is why awareness of anthrax disease symptoms, causes, and treatment is genuinely life-saving knowledge.

Antibiotic Treatment

Antibiotics are the cornerstone of anthrax treatment and are effective against the bacteria — but cannot neutralize toxins already released into the body. The most commonly used antibiotics include:

• Ciprofloxacin — A fluoroquinolone antibiotic; first-line treatment for all forms of anthrax in adults and children
• Doxycycline — A tetracycline antibiotic; effective alternative, particularly for post-exposure prophylaxis
• Amoxicillin — Used for naturally occurring anthrax strains sensitive to penicillin; not appropriate for engineered bioterrorism strains

For cutaneous anthrax, a 7–10 day course of antibiotics is typically sufficient and highly effective — bringing the fatality rate from ~20% untreated to less than 1% with treatment.

For inhalation, gastrointestinal, and injection anthrax, treatment requires a minimum of 60 days of antibiotic therapy — because anthrax spores can remain dormant in the lungs for weeks after initial exposure before germinating.

Antitoxin Therapy

Because antibiotics alone cannot neutralize anthrax toxins once released, antitoxin medications have been developed and stockpiled specifically for anthrax emergencies. These include:

• Raxibacumab — A monoclonal antibody that binds to the protective antigen component of anthrax toxin, blocking it from entering cells
• Obiltoxaximab — Another monoclonal antibody approved for inhalation anthrax treatment and post-exposure prophylaxis
• Anthrax Antitoxin (human) — Derived from plasma of vaccinated donors; provides passive immunity against anthrax toxins

These antitoxin therapies are part of national emergency stockpiles in the United States and other high-readiness nations — maintained specifically for rapid deployment in bioterrorism events or large natural outbreaks.

Supportive Care

Beyond antibiotics and antitoxins, severe anthrax cases require intensive supportive care — mechanical ventilation for respiratory failure, IV fluids for shock management, vasopressors to maintain blood pressure, and drainage of pleural effusions that accumulate around the lungs in inhalation anthrax.

---

Anthrax Prevention and Vaccine

Preventing anthrax involves a combination of vaccination for high-risk individuals, occupational safety practices, animal disease control, and food safety measures. For most people in low-risk settings, simple awareness and food safety precautions are sufficient.

The Anthrax Vaccine

The Anthrax Vaccine Adsorbed (AVA) — marketed as BioThrax — is the only licensed anthrax vaccine for humans in the United States. It is not a live vaccine and cannot cause anthrax. The vaccine is approved for:

• Pre-exposure vaccination — For people at high occupational risk: laboratory workers, military personnel in high-risk deployments, and certain veterinarians
• Post-exposure prophylaxis — Given alongside antibiotics for 60 days following known or suspected exposure to anthrax spores

The pre-exposure vaccination schedule consists of an initial series of injections followed by annual boosters. Side effects are generally mild — localized redness, swelling, and tenderness at the injection site.

Practical Prevention Measures

• Farmers and livestock workers — Vaccinate animals in known anthrax-endemic regions; never handle carcasses of animals that died suddenly without protective equipment; report unexplained animal deaths to veterinary authorities immediately
• Workers handling animal products — Use appropriate personal protective equipment (PPE) including gloves, masks, and protective clothing when handling hides, wool, or bone products from endemic regions
• Food safety — Never eat meat from animals that died suddenly without veterinary inspection; ensure all meat is thoroughly cooked
• Travelers to endemic regions — Avoid contact with sick or dead animals; do not purchase uninspected animal products
• Laboratory safety — Strictly follow biosafety level 2 or 3 protocols when working with Bacillus anthracis cultures

---

Anthrax and Bioterrorism: What You Should Know

Anthrax gained worldwide public attention in October 2001 when letters containing anthrax spores were mailed to media organizations and US Senate offices in the weeks following the September 11 attacks. Twenty-two people developed anthrax infection — 11 cutaneous and 11 inhalation — and five people died.

This event demonstrated both the real threat anthrax poses as a biological weapon and the effectiveness of rapid public health response. Within days of the first cases being identified, antibiotic prophylaxis was offered to thousands of potentially exposed individuals — preventing what could have been a far larger outbreak.

Anthrax spores are considered one of the most dangerous potential biological weapons because they can be produced relatively easily, survive for extended periods in the environment, and cause rapid death when inhaled. The CDC classifies Bacillus anthracis as a Category A bioterrorism agent — the highest priority classification, reserved for agents that pose the greatest risk to public health.

Governments worldwide maintain Strategic National Stockpiles of antibiotics, antitoxins, and vaccines specifically for rapid deployment in the event of a bioterrorism attack involving anthrax. Emergency response protocols are tested and updated regularly to ensure preparedness.

---

Frequently Asked Questions

Can anthrax spread from person to person?

No. Anthrax does not spread from person to person — not through casual contact, respiratory droplets, or any other human-to-human route. Every case of human anthrax traces back to contact with anthrax spores in the environment, infected animals, animal products, or deliberately released biological material. Healthcare workers treating anthrax patients do not need to take special airborne or droplet precautions beyond standard infection control measures.

How long do anthrax spores survive in the environment?

Anthrax spores are extraordinarily resilient. Under favorable conditions — dry soil with appropriate pH and nutrient levels — anthrax spores can remain viable and infectious for decades, and potentially over a century. Historical anthrax burial grounds from the 19th and early 20th centuries have been found to still contain viable spores. This persistence in the environment is one of the key reasons anthrax remains a public health concern even in regions where the disease has not been seen in many years.

What does a cutaneous anthrax lesion look like?

A cutaneous anthrax lesion begins as a small raised bump resembling an insect bite, progresses to a fluid-filled blister, and then forms a distinctive painless ulcer with a black, necrotic (dead tissue) center called an eschar. The surrounding skin is typically swollen and may feel warm. The painlessness of the lesion is one of its most distinguishing features — an infected insect bite or spider bite would typically be quite painful, whereas the anthrax eschar is characteristically not.

Is inhalation anthrax always fatal?

Not always — but it is the most deadly form of anthrax disease. Historically, the fatality rate for inhalation anthrax was close to 100%. With modern intensive care, aggressive antibiotic therapy, and antitoxin treatment, some patients survive — but the fatality rate remains approximately 80% even with treatment. Survival is most strongly associated with how early treatment is initiated. Patients who begin treatment before the second, severe phase of illness have significantly better outcomes.

What should I do if I think I’ve been exposed to anthrax?

Seek emergency medical care immediately and inform healthcare providers of the potential exposure. Do not wait for symptoms to develop — post-exposure prophylaxis with antibiotics is most effective when started as early as possible after exposure. If you believe the exposure may be related to a deliberate release or suspicious package, also contact law enforcement and local public health authorities immediately. Time is critical in anthrax exposure — every hour matters.

Does the anthrax vaccine cause anthrax?

No. The Anthrax Vaccine Adsorbed (BioThrax) does not contain live bacteria and cannot cause anthrax infection. It is made from a cell-free filtrate containing the protective antigen protein — the component of anthrax toxin that stimulates immunity. Common side effects are limited to localized redness, swelling, and tenderness at the injection site. Serious adverse events are rare. The vaccine is safe and has been used in military personnel for decades.

---

---

Medical Disclaimer: The information provided in this article is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. Anthrax is a serious, potentially life-threatening infectious disease that requires immediate professional medical evaluation and management. If you suspect anthrax exposure or infection, seek emergency medical care immediately and contact your local public health authority. BestInMeds.com does not endorse any specific medication, vaccine brand, or treatment protocol. Always follow the guidance of qualified healthcare professionals and public health authorities.